- Filed
- May 13, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 7, 2026 | 62.79M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 62.74M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 60.73M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $11K |
| Capex restated | Q1 2026 · Mar 31, 2025 | $2K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$1.16M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | −$3.47M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $10.31M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $16.67M |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $6.65M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $4.81M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $6.25M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $2.19M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $5.9M |
| Stockholders Equity restated | Q1 2026 · Mar 31, 2025 | $14.54M |
| Stockholders Equity restated | Q1 2026 · Dec 31, 2024 | $11.11M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $16.3M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $9.71M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $38.37M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $38.28M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $17.76M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $20.63M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $40.56M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $44.18M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.08 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.02 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.08 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.02 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $8.15M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $8.43M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $1.03M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $1.66M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$5.13M |
| Net Income restated | Q1 2026 · Mar 31, 2025 | −$1.48M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$3.04M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$3.89M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $6.13M |
| Gross Profit restated | Q1 2026 · Mar 31, 2025 | $6.21M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $2.73M |
| Cost Of Revenue restated | Q1 2026 · Mar 31, 2025 | $2.52M |